Mechanisms and Medicines for Remyelination.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27860545.
- Also identified by DOI 10.1146/annurev-med-050715-104400.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Demyelination of central nervous system axons, associated with traumatic injury and demyelinating diseases such as multiple sclerosis, causes impaired neural transmission and ultimately axon degeneration. Consequently, extensive research has focused on signaling systems that promote myelinating activity of oligodendrocytes or promote production of new oligodendrocytes from oligodendrocyte progenitor cells. Many receptor systems, notably including growth factor receptors and G protein-coupled receptors, control myelination. A number of recent clinical trials target these receptor signaling pathways.
Medical subject headings
- Demyelinating Diseases
- Protein Kinases
- Receptor Protein-Tyrosine Kinases
- Remyelination